Science News
from research organizations

MR Imaging Accurately Determines Prostate Cancer Treatment Failure

Date:
May 19, 2008
Source:
American Roentgen Ray Society
Summary:
Dynamic contrast-enhanced MRI plus diffusion weighted imaging can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.
Share:
         
Total shares:  
FULL STORY

Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.

The study included 27 patients who had increased levels of prostate specific antigen after being treated with high-intensity focused ultrasonic (HIFU) ablation; 18 of these patients had local tumor progression seen at biopsy. DCE-MRI and DWI had about a 72% accuracy rate in determining which patients needed additional treatment because they had residual or recurrent cancer, said Chan Kyo Kim, MD, lead author of the study. The study found that DWI had fewer false positives than DCE-MRI, but DCE-MRI had fewer false negatives.

"After HIFU ablation, the normal anatomy of the prostate gland is completely lost or deformed making it difficult to distinguish benign tissue from cancer," said Dr. Kim. The two imaging studies together, which can be done in about seven minutes, can overcome that challenge, he said.

HIFU is becoming more common as a prostate cancer treatment option, particularly for those persons who can't or don't want to undergo a radical prostatectomy, said Dr. Kim.

The study appears in the May issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "MR Imaging Accurately Determines Prostate Cancer Treatment Failure." ScienceDaily. ScienceDaily, 19 May 2008. <www.sciencedaily.com/releases/2008/05/080519155128.htm>.
American Roentgen Ray Society. (2008, May 19). MR Imaging Accurately Determines Prostate Cancer Treatment Failure. ScienceDaily. Retrieved April 26, 2015 from www.sciencedaily.com/releases/2008/05/080519155128.htm
American Roentgen Ray Society. "MR Imaging Accurately Determines Prostate Cancer Treatment Failure." ScienceDaily. www.sciencedaily.com/releases/2008/05/080519155128.htm (accessed April 26, 2015).

Share This Page:


Health & Medicine News
April 26, 2015

Latest Headlines
updated 12:56 pm ET